October 26, 2015 Early statin use may give long-term heart benefits Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds.
October 26, 2015 Use of cholesterol-lowering meds on the rise The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds
October 26, 2015 New recommendations for overweight people with heart risks Overweight patients with risk factors for heart disease should be sent by their doctors for "intensive behavioral counseling" about diet or exercise, according to new recommendations from the United States Preventive Services Task Force (USPSTF).
October 26, 2015 Poverty-linked heart risks greatest for poor black women, younger adults Among African American adults with low education and income levels, the increase in risk of heart disease or stroke associated with living in poverty is largest for women and people under age 50, according to a large new study.
October 25, 2015 How much do chronic diseases cost in the US? The most expensive health condition in the United States is cardiovascular disease, according to a new report from the Centers for Disease Control and Prevention (CDC).
October 25, 2015 Feeling grateful may improve health for heart failure patients Feeling grateful may help heart failure patients heal both physically and emotionally, say U.S. researchers.
October 25, 2015 Scientists identify people most likely to benefit from statins The American Heart Association’s 2013 recommendation for expanded statin use has raised eyebrows over whether the medications are now prescribed too much. But researchers at Washington University have found that analyzing genetics may help doctors determine who is most likely to benefit from the cholesterol-lowering therapy.
October 25, 2015 Psoriasis or rheumatoid arthritis linked to heart risk Several conditions that stem from a malfunctioning immune system – psoriasis, psoriatic arthritis and rheumatoid arthritis – may create a higher than average risk for heart-related problems and death, a new study finds.
October 24, 2015 Novartis heart failure drug provides host of benefits, study says An experimental heart failure medicine from Novartis that previously showed it reduced death and hospitalizations also curtailed worsening of symptoms, need for additional therapy and emergency room visits, adding to evidence that it will become the drug of choice once approved.
